Latest News in the pharma Industry

Policy & Regulation

Merck Receives Positive CHMP Opinion for Keytruda for the Treatment of Advanced Melanoma

Merck Receives Positive CHMP Opinion for Keytruda for the Treatment of Advanced Melanoma

25 May 2015

Read more 
BMS Receives Positive CHMP Opinion in the EU for Nivolumab (Opdivo, Nivolumab BMS) for the Treatment of Advanced Squamous NSCLC in Previously-Treated Patients

BMS Receives Positive CHMP Opinion in the EU for Nivolumab (Opdivo, Nivolumab BMS) for the Treatment of Advanced Squamous NSCLC in Previously-Treated Patients

22 May 2015

Read more 
BMS Receives Amended FDA Breakthrough Therapy Designation for Investigational Daclatasvir-Based Hepatitis C Regimen

BMS Receives Amended FDA Breakthrough Therapy Designation for Investigational Daclatasvir-Based Hepatitis C Regimen

21 May 2015

Read more 
Baxter Receives FDA Approval for 0.9% Sodium Chloride Injection, USP from Sabinanigo, Spain, Facility for the US Market

Baxter Receives FDA Approval for 0.9% Sodium Chloride Injection, USP from Sabinanigo, Spain, Facility for the US Market

20 May 2015

Read more 
FDA Performs GMP and Pre-Approval Inspections of Impax's Hayward Facility

FDA Performs GMP and Pre-Approval Inspections of Impax's Hayward Facility

12 May 2015

Read more 
Novartis Lung Cancer Drug Zykadia Gains EU Approval, Providing New Therapy for Certain Patients with ALK+ NSCLC

Novartis Lung Cancer Drug Zykadia Gains EU Approval, Providing New Therapy for Certain Patients with ALK+ NSCLC

8 May 2015

Read more 
Novartis Lung cancer Drug Zykadia Gains EU Approval, Providing New Therapy for Certain Patients with ALK+ NSCLC

Novartis Lung cancer Drug Zykadia Gains EU Approval, Providing New Therapy for Certain Patients with ALK+ NSCLC

7 May 2015

Read more 
FDA Issues Proposed Rule to Address Data Gaps for Certain Active Ingredients in Healthcare Antiseptics?

FDA Issues Proposed Rule to Address Data Gaps for Certain Active Ingredients in Healthcare Antiseptics?

1 May 2015

Read more 
Lilly's Cyramza (Ramucirumab) Receives Fourth FDA Approval

Lilly's Cyramza (Ramucirumab) Receives Fourth FDA Approval

27 Apr 2015

Read more 
BMS Receives Positive CHMP Opinion in the EU for Nivolumab

BMS Receives Positive CHMP Opinion in the EU for Nivolumab

27 Apr 2015

Read more 
FDA Issues Draft Guidance for Industry on Electronic and Non-Electronic Submissions of Promotional Materials for Human Prescription Drugs and Biologic Products?

FDA Issues Draft Guidance for Industry on Electronic and Non-Electronic Submissions of Promotional Materials for Human Prescription Drugs and Biologic Products?

22 Apr 2015

Read more 
Sandoz Receives FDA Approval for Glatopa as the First Generic Competitor to MS Therapy Copaxone 20 mg

Sandoz Receives FDA Approval for Glatopa as the First Generic Competitor to MS Therapy Copaxone 20 mg

17 Apr 2015

Read more